Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 5, 2019
Age-stratified prevalence, treatment status, and associated factors of hypertension among US adults following application of the 2017 ACC/AHA guidelineGulam Muhammed Al Kibria, Amy Nemirovsky, Atia Sharmeen, et al.Preventing Chronic Disease|February 1, 2019
Estimated Change in Prevalence and Trends of Childhood Blood Pressure Levels in the United States After Application of the 2017 AAP GuidelineGulam Muhammed Al Kibria, Krystal Swasey, Atia Sharmeen, et al.Evaluation & the Health Professions|May 27, 2011
Effects of incentives and prenotification on response rates and costs in a national web survey of physiciansJennifer Dykema, John Stevenson, Brendan Day, et al.BMJ Open|February 7, 2020
Differences in prevalence and associated factors of underweight and overweight/obesity according to rural-urban residence strata among women of reproductive age in Bangladesh: evidence from a cross-sectional national surveyMohammad Rashidul Hashan, Rajat Das Gupta, Brendan Day, et al.Journal of Gambling Studies|April 10, 2020
Evaluating for Differences by Race/Ethnicity in the Association Between Income and Gambling DisorderBrendan Day, Geoffrey Rosenthal, Fiyinfolu Adetunji, et al.Global Health Research and Policy|September 14, 2019
Prevalence and factors associated with underweight, overweight and obesity among women of reproductive age in IndiaGulam Muhammed Al Kibria, Krystal Swasey, Md Zabir Hasan, et al.Clinical Pharmacology and Therapeutics|May 31, 2021
The Impact of Variability in Patient Exposure During Premarket Clinical Development on Postmarket Safety OutcomesSanae Cherkaoui, Ellen Pinnow, Ilynn Bulatao, et al.Clinical Pharmacology and Therapeutics|June 20, 2020
Postmarketing Safety-Related Regulatory Actions for New Therapeutic Biologics Approved in the United States 2002-2014: Similarities and Differences With New Molecular EntitiesIlynn Bulatao, Ellen Pinnow, Brendan Day, et al.Pharmacoepidemiology and Drug Safety|September 6, 2022
Thromboembolic events after Ad.26.COV2.S COVID-19 vaccine: Reports to the Vaccine Adverse Event Reporting SystemEmily Jane Woo, Adamma Mba-Jonas, Alisha Thomas, et al.Pharmacoepidemiology and Drug Safety|February 22, 2023
Reporting rates for VAERS death reports following COVID-19 vaccination, December 14, 2020-November 17, 2021Brendan Day, David Menschik, Deborah Thompson, et al.Pageof 1